TMCnet News
IntriCon Announces Changes to Board of Directors and Leadership Team PromotionsRaymond Huggenberger Appointed to Board of Directors ARDEN HILLS, Minn., April 29, 2019 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced changes to its Board of Directors and promotions within the current leadership team. Ray Huggenberger Appointed to Board of Directors “We are extremely delighted to welcome Ray to our team during this dynamic stage of our growth. He brings an incredible wealth of experience and strategic vision to our business specifically in medical device commercialization. Importantly, we are confident his deep knowledge of direct-to consumer operations will be invaluable as we expand our opportunity in the hearing health market,” said Mark Gorder, President and Chief Executive Officer of IntriCon. “As we continue to deliver high-value parts and products that enhance the well-being of the customers that we and our partners serve, having a diverse set of backgrounds and skillsets on the board is critical to executing with maximum efficiency.” Mr. Huggenberger previously served as Inogen’s President and Chief Executive Officer. Prior to joining Inogen in 2008, he held various management positions with Sunrise Medical Inc., a global manufacturer and distributor of durable medical equipment, culminating as its President and Chief Operating Officer. Phil Smith Elected Chairman of the Board Mr. Smith brings with him more than 20 years of experience in healthcare, including roles in mergers and acquisitions, finance and executive management. He currently serves as a managing director at Duff & Phelps’s investment banking group, where he focuses on the healthcare industry. “We are delighted that the Board elected Phil as the new Chairman. Having worked closely with him s for the past several years, we are very confident he will continue to create shareholder value for the company,” said Gorder. “Under the leadership of Mike McKenna, the company has been transformed into a leading supplier of miniature and micro-miniature body-worn devices. On behalf of the IntriCon Executive Team and Board of Directors, I would like to personally thank Mike for his faithful and longstanding 21 years of service to the company and wish him well in his retirement,” added Gorder. Chief Financial Officer Scott Longval Assumes Additional Role of Chief Operating Officer “Scott has been a pleasure to work alongside and a great asset to the Company in his role as CFO. During his tenure he has been an effective steward of our capital resources, driven revenue growth, and been instrumental in the completion of several key acquisitions and equity financings. When we made the decision to expand our leadership team by adding a COO, his deep knowledge of our business, as well as his strong leadership skills, made him the ideal candidate to assume this new role,” said Gorder. “A fundamental component of this role is to provide the leadership, management and vision necessary for the company’s next phase of growth, and I am confident that Scott’s strong business acumen will help us realize our future growth and operating efficiency goals.” Michael Geraci, Dennis Gonsior and Greg Gruenhagen Promoted to Senior Vice President Mr. Geraci joined IntriCon more than 36 years ago and has played a key role in the growth of the business through his consistent leadership and management of sales and marketing. In his new role, Mr. Geraci will also oversee the recently created new business development function, a key priority of company. Mr. Gonsior joined IntriCon more than 37 years ago and through his dedication and strong leadership has established a world-class, global manufacturing operation. In his new role, Mr. Gonsior will oversee the efficient integration of our global capacity expansion. Mr. Gruenhagen joined IntriCon more than 32 years ago and has played a key role in the success of the company by managing our quality management system to meet the rigors of class I, II and III medical devices. In his new role, Mr. Gruenhagen will assume responsibility for growing international regulatory affair efforts as well as support the integration of our global capacity expansion. About IntriCon Corporation Investor Relations Contact
|
